AIMT
Aimmune Therapeutics
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
74 hedge funds and large institutions have $319M invested in Aimmune Therapeutics in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
74
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$11.3M | |
| 2 | +$8.26M | |
| 3 | +$4.59M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.85M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$2.46M |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$7.07M | |
| 3 | -$3.18M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.03M |
| 5 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$1.3M |